AL Sydbank A/S
26.8.2026 07:54:00 CEST | Globenewswire | Press release
Financial calendar
Financial calendar
Company Announcement No 46/2026 | Peberlyk 4 6200 Aabenraa Denmark Tel +45 74 37 37 37 AL Sydbank A/S CVR No DK 12626509, Aabenraa al-sydbank.com |
| 26 August 2026 |
Dear Sirs
Financial calendar
In 2026 and 2027 the Group’s preliminary announcement of financial statements will be released as follows:
– Interim Report – Q1-Q3 2026
5 November 2026
– Announcement of the 2026 financial statements
3 March 2027
– Annual General Meeting 2027
18 March 2027
– Interim Report – Q1 2027
28 April 2027
– Interim Report – First Half 2027
25 August 2027
– Interim Report – Q1-Q3 2027
3 November 2027
The preliminary announcements of financial statements are expected to be released at 8.00am on the dates listed above. The preliminary announcements of financial statements will be available at al-sydbank.dk and al-sydbank.com immediately following their release.
Annual General Meeting 18 March 2027
Business to be transacted at the Bank’s AGM must have been received by the Bank in writing no later than on 3 February 2027. Any dividend will be available in shareholders’ return accounts on Tuesday 23 March 2027.
Yours sincerely
AL Sydbank A/S
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CGTN20.9.2026 11:26:23 CEST | Pressemeddelelse
CGTN:CGTN-undersøgelse | Hvorfor får SCO’s løsning på global styring stor opmærksomhed?
Chery Auto20.9.2026 06:23:11 CEST | Press release
LEPAS Expands Global Presence with Progress Across Multiple Markets
Sunwin20.9.2026 05:13:15 CEST | Press release
MG Commercial Makes IAA Transportation 2026 Debut with Two All-Electric Buses
CGTN19.9.2026 08:41:28 CEST | Press release
CGTN:CGTN Poll | Why is the SCO Solution for Global Governance Drawing Wide Attention?
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom